123 related articles for article (PubMed ID: 8304975)
1. Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo.
Vásquez-Vivar J; Augusto O
Biochem Pharmacol; 1994 Jan; 47(2):309-16. PubMed ID: 8304975
[TBL] [Abstract][Full Text] [Related]
2. Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling.
Vásquez-Vivar J; Augusto O
J Biol Chem; 1992 Apr; 267(10):6848-54. PubMed ID: 1313024
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates.
Link CM; Theoharides AD; Anders JC; Chung H; Canfield CJ
Toxicol Appl Pharmacol; 1985 Nov; 81(2):192-202. PubMed ID: 4060148
[TBL] [Abstract][Full Text] [Related]
4. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
[TBL] [Abstract][Full Text] [Related]
5. ESR detection of free radical intermediates during autoxidation of 5-hydroxyprimaquine.
Vasquez-Vivar J; Augusto O
Free Radic Res Commun; 1990; 9(3-6):383-9. PubMed ID: 2167276
[TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.
Fletcher KA; Barton PF; Kelly JA
Biochem Pharmacol; 1988 Jul; 37(13):2683-90. PubMed ID: 2839199
[TBL] [Abstract][Full Text] [Related]
7. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
9. Direct ESR detection of a free radical intermediate during the peroxidase-catalyzed oxidation of the antimalarial drug primaquine.
Augusto O; Schreiber J; Mason RP
Biochem Pharmacol; 1988 Jul; 37(14):2791-7. PubMed ID: 2840077
[TBL] [Abstract][Full Text] [Related]
10. Side-chain hydroxylation in the metabolism of 8-aminoquinoline antiparasitic agents.
Idowu OR; Peggins JO; Brewer TG
Drug Metab Dispos; 1995 Jan; 23(1):18-27. PubMed ID: 7720521
[TBL] [Abstract][Full Text] [Related]
11. Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes.
Fasinu PS; Nanayakkara NPD; Wang YH; Chaurasiya ND; Herath HMB; McChesney JD; Avula B; Khan I; Tekwani BL; Walker LA
Malar J; 2019 Jan; 18(1):30. PubMed ID: 30700282
[TBL] [Abstract][Full Text] [Related]
12. A mechanism for primaquine mediated oxidation of NADPH in red blood cells.
Thornalley PJ; Stern A; Bannister JV
Biochem Pharmacol; 1983 Dec; 32(23):3571-5. PubMed ID: 6316988
[TBL] [Abstract][Full Text] [Related]
13. Peroxidation of the antimalarial drug primaquine: characterization of a benzidine-like metabolite with methaemoglobin-forming activity.
Morais Mda S; Augusto O
Xenobiotica; 1993 Feb; 23(2):133-9. PubMed ID: 8498077
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of certain hydroxy analogues of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes.
Allahyari R; Strother A; Fraser IM; Verbiscar AJ
J Med Chem; 1984 Mar; 27(3):407-10. PubMed ID: 6699888
[TBL] [Abstract][Full Text] [Related]
15. Primaquine-induced hemolytic anemia: formation of free radicals in rat erythrocytes exposed to 6-methoxy-8-hydroxylaminoquinoline.
Bolchoz LJ; Gelasco AK; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2002 Dec; 303(3):1121-9. PubMed ID: 12438535
[TBL] [Abstract][Full Text] [Related]
16. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine.
Bowman ZS; Morrow JD; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2005 Aug; 314(2):838-45. PubMed ID: 15840764
[TBL] [Abstract][Full Text] [Related]
17. Oxidant stress in malaria as probed by stable nitroxide radicals in erythrocytes infected with Plasmodium berghei. The effects of primaquine and chloroquine.
Deslauriers R; Butler K; Smith IC
Biochim Biophys Acta; 1987 Dec; 931(3):267-75. PubMed ID: 3315005
[TBL] [Abstract][Full Text] [Related]
18. Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro.
Baird JK; McCormick GJ; Canfield CJ
Biochem Pharmacol; 1986 Apr; 35(7):1099-106. PubMed ID: 3754446
[TBL] [Abstract][Full Text] [Related]
19. Role of metabolism and oxidation-reduction cycling in the cytotoxicity of antitumor quinoneimines and quinonediimines.
Powis G; Hodnett EM; Santone KS; See KL; Melder DC
Cancer Res; 1987 May; 47(9):2363-70. PubMed ID: 3032421
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites--I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin.
Agarwal S; Gupta UR; Gupta RC; Anand N; Agarwal SS
Biochem Pharmacol; 1988 Dec; 37(24):4605-9. PubMed ID: 3202898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
